Jazz Pharmaceuticals PLC (JAZZ)
127.59
-0.93
(-0.72%)
USD |
NASDAQ |
Jun 08, 16:00
127.43
-0.16
(-0.13%)
After-Hours: 20:00
Jazz Pharmaceuticals Cash from Investing (TTM): -413.76M for March 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -413.76M |
| December 31, 2022 | -446.23M |
| September 30, 2022 | -131.94M |
| June 30, 2022 | -163.36M |
| March 31, 2022 | -5.987B |
| December 31, 2021 | -5.212B |
| September 30, 2021 | -5.129B |
| June 30, 2021 | -5.382B |
| March 31, 2021 | -210.46M |
| December 31, 2020 | -1.008B |
| September 30, 2020 | -1.240B |
| June 30, 2020 | -1.120B |
| March 31, 2020 | -381.43M |
| December 31, 2019 | -155.30M |
| September 30, 2019 | 43.74M |
| June 30, 2019 | 11.66M |
| March 31, 2019 | -176.29M |
| December 31, 2018 | -394.49M |
| September 30, 2018 | -466.36M |
| June 30, 2018 | -477.96M |
| March 31, 2018 | -317.52M |
| December 31, 2017 | -268.95M |
| September 30, 2017 | -238.93M |
| June 30, 2017 | -1.567B |
| March 31, 2017 | -1.743B |
| Date | Value |
|---|---|
| December 31, 2016 | -1.751B |
| September 30, 2016 | -1.753B |
| June 30, 2016 | -226.79M |
| March 31, 2016 | -32.54M |
| December 31, 2015 | -2.255M |
| September 30, 2015 | -13.06M |
| June 30, 2015 | -91.04M |
| March 31, 2015 | -92.15M |
| December 31, 2014 | -1.068B |
| September 30, 2014 | -1.057B |
| June 30, 2014 | -976.59M |
| March 31, 2014 | -967.02M |
| December 31, 2013 | -16.26M |
| September 30, 2013 | 74.03M |
| June 30, 2013 | 73.43M |
| March 31, 2013 | -484.24M |
| December 31, 2012 | -395.29M |
| September 30, 2012 | -548.08M |
| June 30, 2012 | -557.96M |
| March 31, 2012 | 2.467M |
| December 31, 2011 | -81.23M |
| September 30, 2011 | -16.75M |
| June 30, 2011 | -3.93M |
| March 31, 2011 | -4.285M |
| December 31, 2010 | -2.143M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.987B
Minimum
Mar 2022
43.74M
Maximum
Sep 2019
-1.422B
Average
-430.00M
Median
Cash from Investing (TTM) Benchmarks
| Alkermes PLC | 68.95M |
| Perrigo Co PLC | -2.041B |
| Horizon Therapeutics PLC | -135.03M |
| Iterum Therapeutics PLC | 9.47M |
| Mallinckrodt PLC | -- |